Liver transplantation: current status and future prospects.
The enormous progress that has been made in liver transplantation over the past two decades has culminated in survival approaching 90% at 12 months. The success of the procedure combined with the widening spectrum of disease processes deemed amenable to liver transplantation has meant that there are too few donors for those awaiting transplantation. This has extrapolated to many patients having such advanced disease by the time a suitable donor liver is available, that they are almost non-transplantable. The immediate options facing the transplant community are to decrease the number of patients listed or to increase the number of living donor transplants. Alternatives to liver transplantation such as hepatocyte transplantation, gene therapy, xenotransplantation and the bioartificial liver are being sought but, at best, are some way from clinical application. It is anticipated that a number of liver diseases that are indications for liver transplantation at this time will have progression arrested or will be cured by medical therapy in the future.
Strong
R W
RW
Department of Surgery, Princess Alexandra Hospital, Ipswich Road, Brisbane Qld 4102, Australia. strongr@health.qld.gov.au
D000328:Adult; D002648:Child; D022781:Hepatocytes / Q000637:transplantation; D006801:Humans; D008107:Liver Diseases / Q000628:therapy; D016031:Liver Transplantation / Q000379:methods / Q000401:mortality / Q000639:trends*; D018579:Patient Selection; D015996:Survival Rate; D014019:Tissue Donors